Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma	Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm	Recruiting	Phase 2	2022-08-01		NCT05025813

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Merck Sharp & Dohme LLC	650
Queensland Health	3

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chris O'Brien Lifehouse	Camperdown	Australia	46
Princess Alexandra Hospital	Woolloongabba	Australia	106
Royal Brisbane and Women's Hospital	Herston	Australia	35

Clinical trials